IL166122A0 - Methods of treating microbial infections in humansand animals - Google Patents
Methods of treating microbial infections in humansand animalsInfo
- Publication number
- IL166122A0 IL166122A0 IL16612205A IL16612205A IL166122A0 IL 166122 A0 IL166122 A0 IL 166122A0 IL 16612205 A IL16612205 A IL 16612205A IL 16612205 A IL16612205 A IL 16612205A IL 166122 A0 IL166122 A0 IL 166122A0
- Authority
- IL
- Israel
- Prior art keywords
- humansand
- animals
- methods
- microbial infections
- treating microbial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39457302P | 2002-07-09 | 2002-07-09 | |
| PCT/US2003/021469 WO2004004712A1 (en) | 2002-07-09 | 2003-07-09 | Methods of treating microbial infections in humans and animals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL166122A0 true IL166122A0 (en) | 2006-01-15 |
Family
ID=30115736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16612205A IL166122A0 (en) | 2002-07-09 | 2005-01-03 | Methods of treating microbial infections in humansand animals |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060135568A1 (zh) |
| EP (1) | EP1539147A4 (zh) |
| JP (1) | JP4493494B2 (zh) |
| KR (1) | KR20050047519A (zh) |
| CN (2) | CN1671384A (zh) |
| AU (1) | AU2003248896B2 (zh) |
| BR (1) | BRPI0312654A2 (zh) |
| CA (1) | CA2491573A1 (zh) |
| EA (1) | EA200500177A1 (zh) |
| IL (1) | IL166122A0 (zh) |
| MX (1) | MXPA05000361A (zh) |
| SG (1) | SG149701A1 (zh) |
| WO (1) | WO2004004712A1 (zh) |
| ZA (1) | ZA200500166B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7649012B2 (en) * | 2002-07-09 | 2010-01-19 | Fasgen, Inc. | Compounds, pharmaceutical compositions containing same, and methods of use for same |
| US8653258B2 (en) | 2007-06-08 | 2014-02-18 | Georgia State University Research Foundation, Inc. | Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteria |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2101223A1 (en) * | 1970-08-04 | 1972-03-31 | Nasa | Bacteria determination in urine - by bioluminescence reaction of bacterial atp |
| US5908751A (en) * | 1996-04-26 | 1999-06-01 | Toyo Ink Mfg. Co., Ltd. | Method for detecting and/or determining ATP from microorganism cells in a sample |
| AU768204B2 (en) * | 1998-12-23 | 2003-12-04 | Cumberland Pharmaceuticals Inc. | Glycopeptide derivatives and pharmaceutical compositions containing the same |
| US6448472B1 (en) * | 1999-02-05 | 2002-09-10 | Board Of Regents, The University Of Texas System | Genetic and epigenetic manipulation of ABC transporters and ectophosphatases for the conference of hormone and herbicide resistance |
| CA2364592A1 (en) * | 1999-03-03 | 2000-09-08 | Collin E. Thomas | Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases for the conference of drug resistance and for the loss of drug resistance in biological systems and methods for the detection of ecto-phosphatase inhibitors |
| HN2000000051A (es) * | 1999-05-19 | 2001-02-02 | Pfizer Prod Inc | Derivados heterociclicos utiles como agentes anticancerosos |
| US6376682B1 (en) * | 2000-02-01 | 2002-04-23 | Takama System, Ltd. | Compound with α-glucosidase inhibiting action and method for producing the same |
| US6248790B1 (en) * | 2000-06-29 | 2001-06-19 | Parker Hughes Institute | Treatment of inflammation with 2,4,6-trihydroxy-alpha-rho-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives |
| CN101633650A (zh) * | 2002-07-01 | 2010-01-27 | 法斯根有限责任公司 | 新化合物、包含该化合物的药物组合物及该化合物的应用方法 |
| US7649012B2 (en) * | 2002-07-09 | 2010-01-19 | Fasgen, Inc. | Compounds, pharmaceutical compositions containing same, and methods of use for same |
-
2003
- 2003-07-09 CA CA002491573A patent/CA2491573A1/en not_active Abandoned
- 2003-07-09 SG SG200703939-9A patent/SG149701A1/en unknown
- 2003-07-09 ZA ZA200500166A patent/ZA200500166B/xx unknown
- 2003-07-09 CN CNA038185210A patent/CN1671384A/zh active Pending
- 2003-07-09 MX MXPA05000361A patent/MXPA05000361A/es not_active Application Discontinuation
- 2003-07-09 BR BRPI0312654A patent/BRPI0312654A2/pt not_active IP Right Cessation
- 2003-07-09 KR KR1020057000353A patent/KR20050047519A/ko not_active Application Discontinuation
- 2003-07-09 EA EA200500177A patent/EA200500177A1/ru unknown
- 2003-07-09 AU AU2003248896A patent/AU2003248896B2/en not_active Expired - Fee Related
- 2003-07-09 EP EP03763401A patent/EP1539147A4/en not_active Withdrawn
- 2003-07-09 WO PCT/US2003/021469 patent/WO2004004712A1/en active Application Filing
- 2003-07-09 CN CN200910225906A patent/CN101721412A/zh active Pending
- 2003-07-09 US US10/520,506 patent/US20060135568A1/en not_active Abandoned
- 2003-07-09 JP JP2004520072A patent/JP4493494B2/ja not_active Expired - Fee Related
-
2005
- 2005-01-03 IL IL16612205A patent/IL166122A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003248896B2 (en) | 2010-04-22 |
| KR20050047519A (ko) | 2005-05-20 |
| SG149701A1 (en) | 2009-02-27 |
| EP1539147A4 (en) | 2007-04-25 |
| MXPA05000361A (es) | 2005-09-20 |
| CN101721412A (zh) | 2010-06-09 |
| AU2003248896A1 (en) | 2004-01-23 |
| EA200500177A1 (ru) | 2005-12-29 |
| BRPI0312654A2 (pt) | 2017-05-02 |
| JP2005533834A (ja) | 2005-11-10 |
| ZA200500166B (en) | 2007-08-29 |
| JP4493494B2 (ja) | 2010-06-30 |
| CA2491573A1 (en) | 2004-01-15 |
| US20060135568A1 (en) | 2006-06-22 |
| WO2004004712A1 (en) | 2004-01-15 |
| CN1671384A (zh) | 2005-09-21 |
| EP1539147A1 (en) | 2005-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL172224A0 (en) | Compositions for treating infection in cattle and swine | |
| ZA200507857B (en) | Compositions for treating microbial and parasitic infections in cattle and other animals | |
| HK1072547A1 (en) | Compositions and method for treating infection in cattle and swine | |
| GB2398810B (en) | Well treatment method and system | |
| HK1089676A1 (en) | Formulations and methods for treating rhinosinusitis | |
| EP1531828A4 (en) | METHODS OF TREATING BACTERIAL INFECTIONS AND ASSOCIATED DISEASES | |
| MX263826B (en) | Water treatment system and method | |
| ZA200604779B (en) | Water treatment system and method | |
| EP1812068A4 (en) | METHODS FOR PREVENTING AND TREATING RSV INFECTIONS AND ASSOCIATED DISEASES | |
| IL169701A0 (en) | The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl | |
| EP1659169A4 (en) | DEVICE FOR TREATING CULTURES AND AUTOCULTIVATION DEVICE | |
| EP1461047A4 (en) | COMPOSITIONS AND METHODS FOR TREATING ANIMALS | |
| ZA200604782B (en) | Water treatment system and method | |
| AU2003239132A8 (en) | Methods and compositions for preventing and treating microbial infections | |
| IL180459A0 (en) | Treatment of bacterial infections | |
| AU2003296963A8 (en) | Methods and compositions for treating and preventing ear infections | |
| SG110107A1 (en) | Compound and use in treatment | |
| IL166122A0 (en) | Methods of treating microbial infections in humansand animals | |
| AU2003275433A8 (en) | Compositions and methods for treating pain | |
| GB0323849D0 (en) | Animal treatment system and method thereof | |
| AU2003290506A8 (en) | Methods and devices for treating severe peripheral bacterial infections | |
| DE60336244D1 (de) | Artikelbehandlungssystem und -verfahren | |
| HK1069739A1 (en) | Compositions and methods for treatment of microbial infections | |
| GB2406865B (en) | Well treatment system and method | |
| IL162103A0 (en) | Methods of treating bacterial infections in dogs and cats |